Talawar Tx Inc. has received effectiveness for its S-4 registration statement, paving the way for its securities offering in the biological products sector.
| Name | Talawar Tx Inc. |
|---|---|
| CIK | 0002140859 |
| Tickers | TLWR |
| Exchanges | — |
| Entity type | other |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 415282723 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 781-864-1111 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Talawar Tx Inc. has received effectiveness for its S-4 registration statement, paving the way for its securities offering in the biological products sector.
Talawar Tx Inc. files a proxy statement for a merger with JATT II Acquisition Corp, aiming to enhance its position in the biological products sector.
Talawar Tx Inc. has filed an amended registration statement, signaling strategic moves in the biological products sector as it prepares for a significant corporate transaction.
Talawar Tx Inc. files an amended registration statement, signaling growth in the biological products sector.
12 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-09 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003483 | 333-298621 | 261537696 | 33 | 1771 | ||
| 2026-11-09 | 424B3 | 424B3 | 0001193125-26-453794 | 333-298621 | 261536801 | 33 | 11148883 | |||
| 2026-11-04 | S-4/A | S-4/A | 0001193125-26-446390 | 333-298621 | 261520428 | 33 | 15797093 | 1 | 1 | |
| 2026-10-26 | S-4/A | S-4/A | 0001193125-26-431034 | 333-298621 | 261483552 | 33 | 17636539 | 1 | 1 | |
| 2026-10-05 | S-4/A | S-4/A | 0001193125-26-413188 | 333-298621 | 261438835 | 33 | 16661554 | 1 | 1 | |
| 2026-10-01 | 425 | 425 | 0001193125-26-409995 | 39393 | ||||||
| 2026-09-14 | 425 | 425 | 0001193125-26-389929 | 99479 | ||||||
| 2026-09-10 | 425 | 425 | 0001193125-26-387352 | 24624790 | ||||||
| 2026-08-28 | S-4 | S-4 | 0001193125-26-374324 | 333-298621 | 261339979 | 33 | 25640146 | 1 | 1 | |
| 2026-06-29 | 425 | 425 | 0001193125-26-288377 | 25805 | ||||||
| 2026-06-29 | 425 | 425 | 0001193125-26-288357 | 238966 | ||||||
| 2026-06-29 | 425 | 425 | 0001193125-26-286936 | 11106703 |
One latest value per concept from companyfacts (6 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ffd | NetFeeAmt | NetFeeAmt | USD | 12,709.27 | 2026-08-28 | S-4 | 2026-08-28 | 0001193125-26-374324 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 12,709.27 | 2026-08-28 | S-4 | 2026-08-28 | 0001193125-26-374324 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 92.03M | 2026-08-28 | S-4 | 2026-08-28 | 0001193125-26-374324 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-28 | S-4 | 2026-08-28 | 0001193125-26-374324 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-28 | S-4 | 2026-08-28 | 0001193125-26-374324 | |||
| spac | DeSpacForepartPricePaidOrToBePaidForSecuritiesTotalAmount | DeSpacForepartPricePaidOrToBePaidForSecuritiesTotalAmount | USD | 3.02M | 2026-10-26 | S-4/A | 2026-11-04 | 0001193125-26-446390 |